Several studies have shown that enrolling in chronic condition special needs plans (CNSPs) for chronic diseases could be beneficial. But the exact effect and advantages of CNSPs are not clear. This study aims to investigate the degree of benefit and improved clinical outcomes associated with CSNPs in patients with end-stage kidney disease (ESKD).
This multicenter cohort study included a total of 2,545 patients who were newly enrolled in CSNPs for ESKD. Eligible patients received standard ESKD care with dialysis. The primary outcomes of the study were hospitalizations, laboratory values indicative of metabolic control, Kidney Disease Quality of Life 36-item (KDQOL-36) survey scores, and mortality.
When compared with patients not enrolled in C-SNP, those who were enrolled had lower hospitalization rates, with incidence rate ratios of 0.90 and 0.70 in the facility-matched and county-matched analysis, respectively. Also, when compared with patients who didn’t enroll in CSNPs, enrolled had a reduced mortality risk in the same facilities and counties. However, there were no significant differences in the KDQOL-36 survey scores between the two groups.
The research concluded that patients with ESKD who were enrolled in CSNPs were at a lower risk of hospitalizations and mortality.